US Patent Issued to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK on Dec. 9 for "Methods, compositions, kits and uses thereof targeting and/or treating VRK2 to enhance effectiveness of immune checkpoint inhibitor(s)" (American, Israeli Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,176, issued on Dec. 9, was assigned to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York).

"Methods, compositions, kits and uses thereof targeting and/or treating VRK2 to enhance effectiveness of immune checkpoint inhibitor(s)" was invented by Adam Mor (Old Tappan, N.J.) and Michael Peled (Givatayim, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Exemplary methods, compositions, kits and uses thereof for treating neoplasia are provided. For example, a method can be provided for treating neoplasia in a subject, including administering to the subject a VRK2 (vaccinia-related kinase 2) inhibitor, alone or in combination with a...